Action HAN HANSA INVESTMENT COMPANY LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Hansa Investment Company Limited

Actions

HAN

BMG428941162

Marché Fermé - London S.E.
Autres places de cotation
 17:35:21 12/06/2024 		Varia. 5j. Varia. 1 janv.
210 GBX -2,78% Graphique intraday de Hansa Investment Company Limited -3,23% +5,00%
2023 Hansa Investment Company Limited publie ses résultats pour le semestre clos le 30 septembre 2023 CI
2023 Hansa Biopharma annonce des résultats de haut niveau encourageants pour le premier essai chez l'homme de HNSA-5487 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Hansa Investment Company Limited Expects to Pay Four Interim Dividends for Its Financial Year Ending 31 March 2025
Hansa Investment Company Limited Announces Fourth Interim Dividend for the Financial Year Ended 31 March 2024, Payable on 31 May 2024
Hansa Investment Company Limited Declares Third Interim Dividend for the Financial Year Ending 31 March 2024, Payable on 23 February 2024
Hansa Investment Company Limited Reports Earnings Results for the Half Year Ended September 30, 2023
Hansa Investment Company Limited Declares Second Interim Dividend for the Financial Year Ending 31 March 2024, Payable on November 24, 2023
Hansa Biopharma Announces Encouraging High-Level Results for First-In-Human Trial of HNSA-5487
Hansa Investment Company Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Hansa Investment Company Limited Appoints Dr. Hitto Kaufmann as Chief Scientific Officer
Hansa Investment Company Limited Announces First Patient Treated with Imlifidase in an Investigator-Initiated Phase 2 Study in Anca-Associated Vasculitis
Hansa Investment Company Limited Announces First Interim Dividend for the Year Ended 31 March 2024, Payable on August 25, 2023
Hansa Biopharma Announces Positive Reimbursement Decision for Idefirix in Belgium as Desensitization Treatment for Highly Sensitized Patients in Kidney Transplantation
Hansa Investment Company Limited Expects to Pay Four Interim Dividends for its Financial Year Ending 31 March 2024, Payable on August 2023, November 2023, February 2024 and May 2024 Respectively
Hansa Investment Company Limited Announces Its Fourth Interim Distribution for the Company's Financial Year Ended March 31, 2023, Payable on 26 May 2023
Hansa Investment Company Limited Announces Executive Changes
Hansa Investment Company Limited Announces Third Interim Distribution for the Financial Year Ended March 31, 2023, Payable on February 24, 2023
Hansa Investment Company Limited Reports Earnings Results for the Half Year Ended September 30, 2022
Hansa Investment Company Limited Announces Second Interim Distribution for the Financial Year Ended 31 March 2023, Payable on 25 November 2022
Hansa Investment Company Limited Announces First Interim Distribution for the Financial Year Ending March 31, 2023, Payable on August 26, 2022
Hansa Investment Company Limited Elects Peter Nicklinas Chair of the Board of Directors
Hansa Investment Company Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action HAN
  4. Actualités Hansa Investment Company Limited
  5. Autres langues